Companion Animals Vaccines Market
Market Insights on Companion Animals Vaccines covering sales outlook, demand forecast & up-to-date key trends
Companion Animal Vaccines Market, by Product Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines) & Region - Forecast 2022 - 2028
Global Companion Animals Vaccines Market Snapshot
[220 Pages Report] The market is set to expand 1.4X over the forecast period 2022-2028. The Companion Animals Vaccines Market is expected to grow at a CAGR of 6.9% over the forecast period and record sales worth U.S. $ 4.9 Bn by the end of 2028.
|
Data Points |
Market Insights |
|
Market Value 2022 |
U.S. $ 3.3 Bn |
|
Market Value 2028 |
U.S. $ 4.9 Bn |
|
CAGR 2022-2028 |
6.9% |
|
Share of top 5 countries |
56.6% |
|
Key Players |
The key players of this industry are Bayer Healthcare, Vétoquinol S.A, Boehringer Ingelheim, Ceva Santé Animale, Eli Lilly and Company (Elcano), Heska Corp., Merck Animal Health, Merial (Sanofi), Virbac and Zoetis (Pfizer). |
The global companion animal vaccines market accounts for 31.1% of the global veterinary vaccines market by the end of 2021, which is expected to be valued at the U.S. $ 10.0 Bn in the same year. The growing adoption of companion animals all over the world, humanization of pets and growing awareness of pet insurance are some of the opportunities for the companion animal vaccines market over the forecast period.
Routine vaccine programs for companion animals have eliminated some of the chronic scourges from developed countries. The improved focus on vaccinations campaigns, higher awareness for pet care are fueling the demand for companion animal vaccines. The veterinary healthcare industry is witnessing increased demand for protozoan parasitic vaccines from countries in tropical and sub-tropical regions.
The development of resistance to various chemotherapeutic agents is contributing to increased demand for vaccines over anti-parasitic drugs. In this regard, scientists have noted that the production of third-generation DNA vaccines against protozoan parasites could prove largely helpful. These vaccines are safe as they do not contain any pathogen, are more stable as compared to live attenuated and killed virus in the vaccine and are also cost-effective.
The sales of attenuated live vaccines reached U.S. $ 1.07 Bn by the end of 2021, which would account for 34.3% market share, by the value of the global companion animal vaccines market. The rising incidence of zoonotic diseases is growing awareness about zoonotic diseases and owners are increasingly inclined towards proper care of their pets through effective vaccinations.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
6.85% |
|
H1, 2022 Projected |
7.01% |
|
H1, 2022 Outlook |
6.91% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(+) 06 ↑ |
The comparative analysis and market growth rate of global companion animal vaccines market is studied by Future Market Insights. The variation between the BPS values observed within this market in H1, 2022 - Outlook over H1, 2022 Projected reflects a decline of 10 units.
However A positive BPS growth in H1-2022 over H1-2021 by 06 Basis Point Share (BPS) is demonstrated by the market. This increase is due to increasing number of companion animals which has demanded the need for vaccines, thereby impacting the growth of companion animal vaccines market.
Another reason for surge in the market includes increased awareness about zoonotic diseases and government initiatives to curb anti-microbial resistance among pets.
According to FMI analysis, escalation in BPS is attributed to factors such as increase in adoption of recombinant vaccines and also governments involvement in striving to encourage routine vaccination programs of these companion animals inculcating higher awareness for pet care and also fueling the demand for companion animal vaccines.
In India, the rising western influence has increased pet ownership which has demanded growth of pet vaccination and is favoring overall market growth as well.
Factors such as difficulties in understanding of epidemiology of veterinary diseases which hampers the discovery and production limit for a vaccine to prevent the spread of the disease can restrict market growth in the future.
2015-2021 Companion Animals Vaccines Demand Outlook Compared to 2022-2028 Forecast
According to Future Market Insights (FMI), the demand for companion animal vaccines during the period of 2015 to 2021 expanded at a CAGR of 6.5%. A growing number of pets around the world, increasing awareness of the importance of pet vaccination attributed to the growth of this market over the last few years.
According to the North American Pet Health Insurance Association, approximately 2.2 million pets in the U.S. were covered by health insurance in the year 2018, which was 18% more than the number recorded in the previous year. Pet insurance acts as a decision-maker to the companion animal health value chain that includes third-party payers.
The increasing pet insurance coverage in the U.S and other developed countries is expected to act as a value driver to the Global companion animal vaccines market.
Various governments around the world are encouraging pet owners to vaccinate their pets and avoid the unnecessary use of antibiotics for their treatment since there is an increased prevalence of antimicrobial resistance amongst companion animals. Veterinary vaccines reduce reliance on anthelmintic and antimicrobial drugs for treating infections.
Thus, there is an increased demand for pet vaccination around the world. Furthermore, a reduction in overall drug usage among companion animals in developed markets is fueling demand for preventive healthcare tools such as booster vaccines for companion animals.
According to the American Veterinary Medical Association, around 67% of the households in the U.S. owned either dogs, cats, birds or horses as their companions in the year 2018 and on average, a household spent the U.S $ 614 to the U.S. $ 412 on pet care per year.
Since there is such a high number of companion animals in the U.S., the demand for companion animals vaccines is growing at a steady pace and will follow a similar trend over the forecast period.
The COVID-19 pandemic led to many households adopting pets during the lockdown phase. The American Pet Products Association conducted a “COVID-19 Pulse Study”, which concluded that around 11.3 million households in the U.S. got a new pet during the pandemic.
Amongst the correspondents of the study, 16% of the Generation Z respondents, 13% of the millennials and 3% of the baby boomers’ generations either bought or adopted a pet during the lockdown period.
The key players of this industry are focusing on external partnerships in research driving vaccine development, entering into collaborative partnerships, and acquisitions to expand their businesses around the world.
For instance, in August 2020, Elanco Animal Health Inc. announced the acquisition of the Bayer Animal Health segment. This acquisition enabled Elanco to utilize Bayer’s product range to its full potential during the pandemic by offering the products through online channels, retail sales, telemedicine and doorstep delivery.
In February 2021, Vetoquinol S.A. announced the acquisition of Profender®, which is a spot-on de-wormer product line’s intellectual property rights along with registration and other rights from Elanco Animal Health business in Canada, which was approved by the Canadian Competition Bureau.
The market is consolidated with key players of the companion animal vaccines industry such as Bayer Healthcare, Vétoquinol S.A, Boehringer Ingelheim, Ceva Santé Animale, Eli Lilly and Company (Elcano), Heska Corp., Merck Animal Health, Merial (Sanofi), Virbac and Zoetis (Pfizer).
Future Market Insights expects the global companion animal vaccines market to expand at a CAGR of 6.9% over the forecast period owing to the key player’s various efforts to expand their business around the globe.
What is the impact of COVID-19 on this industry?
The COVID-19 pandemic has had an ambiguous impact on the companion animal vaccines market during the year 2020. The industry experienced stagnation during the first half of 2020 due to lockdown induced reduced patient visits to the veterinary clinics. Moreover, in the latter half of 2020, the market witnessed some steady growth since the lockdown was lifted, the number of client visits to the veterinary hospitals and clinics increased. The increased pet ownership during the lockdown period also had a positive impact on the industry during the pandemic.
Other than the aforementioned impact, the companies manufacturing veterinary vaccines experienced a not so much impact on their sales. For instance, Merck & Co. announced a growth of 7% in their worldwide sales of the animal health segment in 2020.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the key opportunities for manufacturers of companion animal vaccines industry?
Merger & Acquisition activities are gaining a wider footprint within the companion animal vaccines segment in developed markets, which is expected to widen product availability and easy market access. For instance, Elanco Animal Health acquired Kindred Biosciences in August 2021 to expand its product portfolio of dermatology in veterinary medicine and focus on the unmet needs of pet owners and veterinarians.
Many companion animals are relinquished to shelters every year. Due to the increasing growth of companion animals, sterilization is an important process to control overpopulation. This provides an opportunity for companion animal vaccine manufacturers to come up with sterilization vaccines with safety and efficacy, can be suitably administered and undergo secure approvals in countries like the U.S.
The increasing awareness of pet vaccination, zoonotic diseases, along with an increased number of pet ownerships and adoptions can also provide the manufacturers of this industry lucrative opportunities for growth and expansion, especially in the emerging markets.
What are the restraining factors for this market?
Veterinarians have traditionally been responsible for the majority of share of the companion animal products. This share of sales has declined in the U.S, between 2004 and 2014. The shift has moved fast with the introduction of the Fairness to Pet Owners Act in the U.S. Senate in May 2015. This act only allows vets to write prescriptions and allows owners to buy the medicine and vaccines from retailers or pharmacies.
This change requires the companion animal vaccine players to change their strategies of targeting vets and shift to other important stakeholders i.e. pharmacists and retailers. This shift is expected to divert the traditional revenue distribution and veterinary clinic consolidation resulting in affecting the profit margin distribution due to changes in stakeholders.
There exists a large gap in understanding the epidemiology pattern of veterinary diseases due to variations in disease patterns for endemic countries. A typical example is one for Newcastle Disease for poultry and other birds, where the lack of epidemiological knowledge creates a serious economic loss.
Virulent Newcastle disease virus (vNDV) is evolving simultaneously at different locations due to isolates that are distributed worldwide and mutate rapidly. This leads to large knowledge gaps in the development of multiple vNDV genotypes. This hampers the discovery and production limit for a vaccine to prevent the spread of the disease. Recurrent infection in birds allows the maintenance of a reservoir for the viruses.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Country-wise Insights
Will the U.S. remain a key market for companion animal vaccines?
The U.S. hold around 75.4% market share, by revenue of the total market in North America in the year 2021. The companion animal vaccines market is expected to expand at a CAGR of 7.4% in the U.S. over the forecast period (2022-2028). Availability of pet insurance, awareness of zoonotic diseases, government initiatives to curb the anti-microbial resistance amongst pets is some of the factors that attribute to this large share of the U.S.
Why Germany is considered a more lucrative market within Western Europe?
Around 21% of the German households owned a dog and approximately 26% of the households owned a cat in Germany, as of 2020. This is one of the key factors contributing to the growth of the companion animal vaccines market in Germany, which is set to expand at a CAGR of 11.5% over the forecast period (2022-2028). The sales for this industry is valued at U.S. $ 172.9 Mn in the year 2021 in Germany.
What are the factors supporting the sales of companion animal vaccines in India?
India held nearly a 9.1% market share, by revenue in the Asia Pacific market for companion animal vaccines in 2021. The market in India is expected to expand at a CAGR of 5.9% over the forecast period (2022-2028). The increasing influence of western culture came with the increased interest in pet ownership in India. It is estimated that the population of pet dogs in India is expected to be somewhere around 31 million by the end of 2023.
What is the demand outlook of companion animal vaccines in Japan?
The demand for companion animal vaccines in Japan is expected to expand at a CAGR of 6.8% over the forecast period (2022-2028) and is expected to hold a 10.9% market share, by revenue of the global market in 2022. The sales of this market in Japan are expected to be the U.S. $ 364.4 Mn in the year 2022.
Category-wise Insights
What is the companion animal vaccines market value?
The companion animal vaccines market is expected to record sales worth U.S. $ 3.3 Bn in the year 2022 and is set to be U.S. $ 4.98 Bn by the end 0f 2028, which depicts a cumulative CAGR of 6.9% over the forecast period.
Why is the demand for attenuated live vaccines the highest, by product?
Live vaccines use attenuated (or weakened) forms of bacteria that cause the target disease. These vaccines are so similar to natural infections that they help prevent them by producing a strong, long-term immune response. Because of their high efficacy against all diseases, the demand for them is the highest. The sales of attenuated live vaccines are anticipated to be the U.S. $ 1.15 Bn in the year 2022 and are set to expand at a cumulative CAGR of 7.4% over the forecast period.
Why is canine accounting for the highest share, by species type?
The sales for companion animal vaccines by the canine segment are expected to be the U.S. $ 1.69 Bn in the year 2022 and this segment is set to expand at a CAGR of 7.0% over the forecast period (2022-2028). Canine is anticipated to hold 50.9% market share, by revenue of the global market in 2022. According to the World Atlas pet ownership statistics, dogs are ranked first in the list of most popular pets in the U.S. with approximately 48,255,413 households owning a pet dog as of August 2020.
Which distribution channel holds the maximum share in the companion animal vaccines market?
Veterinary Clinics are expected to hold 41.8% market share by revenue of the global companion animal vaccines market in the year 2022 and are set to record sales worth U.S. $ 1.39 Bn in the same year. Since the majority of pet owners prefer visiting a clinic for their pet’s vaccinations, this segment holds such a high share in the market, because they are cost-efficient in comparison to the hospitals.
Competitive Landscape
The key players of this industry are focusing their efforts on mergers and acquisitions, strategic partnerships, investments in research and development to expand their market presence worldwide.
In August 2021, Zoetis announced its plan to acquire Jurox, a private animal health company from Australia. With the completion of this acquisition, Zoetis will be able to capitalize on Jurox’s varied product range and expand its business globally. Since Australia is Zoetis’s fifth-largest revenue-making market, according to their annual report of 2020, this acquisition will help the company strengthen their market presence even further in the country.
Merck Animal Health announced the formation of a strategic partnership with The Street Dog Coalition in the U.S. in January 2021, to provide them with vaccines, medications and treatment of homeless pets.
In October 2021, Boehringer Ingelheim announced a 100 Mn euros investment to expand its veterinary vaccine capacity in France. This investment was made to help the government in France manage the highly contagious transboundary and emerging diseases in animals which may affect public health in the country.
Scope of the Report:
|
Attributes |
Details |
|
Forecast Period |
2022-2028 |
|
Historic Data available for |
2015-2021 |
|
Market Analysis |
USD Million for value |
|
Key Countries covered |
US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa. |
|
Key Segments covered |
Product Type, Distribution Channel, Species Type & Region. |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization and Pricing |
Available upon request |
Companion Animals Vaccines Market, By Category
Product Type:
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
Distribution Channel:
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Retail Pharmacies & Others
Species Type:
- Canine
- Avian
- Feline
Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- The Asia Pacific except Japan
- Japan
- Middle East and Africa
Frequently Asked Questions
The companion animal vaccines industry recorded sales worth U.S. $ 3.11 Bn in the year 2021 and is set to be U.S. $ 4.98 Bn by the end of 2028, which depicts a cumulative CAGR of 6.9% over the forecast period.
The market value of the global animal vaccines market is the U.S. $ 3.11 Bn in the year 2021.
The rising incidence of zoonotic diseases, increased pet ownership, growing awareness of pet vaccination, availability of pet insurances are some of the major factors driving the global companion animals vaccines market growth.
North America holds the largest market share, by revenue of the global companion animal vaccines market with the recorded sales of U.S. $ 935.2 Mn in the year 2021.
The companion animal vaccines market grew at a CAGR of nearly 6.5% from 2015 to 2021.
Table of Content
1. Executive Summary
2. Market Introduction
2.1. Companion Animal Vaccines Market Definition
2.2. Companion Animal Vaccines Market Taxonomy
2.3. Veterinary Vaccines Market
3. Companion Animal Vaccines Market Analysis Scenario
3.1. Regulations and Reimbursement Scenario
3.2. Global Company Market Share Analysis (2021)
3.3. Mechanism for Veterinary Product Approval
3.4. Companion Animal Vaccines Market Overview
3.4.1. List of Active Participants
4. Companion Animal Vaccines Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5. Global Trends
5. Global Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028, By Product Type
5.1. Introduction
5.1.1. Basis Point Share (BPS) Analysis By Product Type
5.1.2. Y-o-Y Growth Projections By Product Type
5.2. Market Size (US$ Mn) 2015-2028, Forecast By Product Type
5.2.1. Attenuated Live Vaccines
5.2.2. Conjugate Vaccines
5.2.3. Inactivated Vaccines
5.2.4. Subunit Vaccines
5.2.5. Toxoid Vaccines
5.2.6. DNA Vaccines
5.2.7. Recombinant Vaccines
5.3. Market Attractiveness Analysis By Product Type
5.4. Prominent Trends
6. Global Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028, By Distribution Channel
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis By Distribution Channel
6.1.2. Y-o-Y Growth Projections By Distribution Channel
6.1.3. Comparative Analysis By Distribution Channel
6.2. Market Size (US$ Mn) 2015-2028, Forecast By Distribution Channel
6.2.1. Veterinary Clinics
6.2.2. Veterinary Hospitals
6.2.3. Veterinary Research Institutes
6.2.4. Retail Pharmacies & Others
6.3. Market Attractiveness Analysis By Distribution Channel
6.4. Prominent Trends
7. Global Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028, By Species Type
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis By Species Type
7.1.2. Y-o-Y Growth Projections By Species Type
7.1.3. Comparative Analysis By Species Type
7.2. Market Size (US$ Mn) 2015-2028, Forecast By Species Type
7.2.1. Canine
7.2.2. Avian
7.2.3. Feline
7.3. Market Attractiveness Analysis By Species Type
8. Global Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028, By Region
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis By Region
8.1.2. Y-o-Y Growth Projections By Region
8.2. Market Size (US$ Mn) 2015-2028, Forecast By Region
8.2.1. North America
8.2.2. Latin America
8.2.3. Western Europe
8.2.4. Eastern Europe
8.2.5. Asia Pacific Excl. Japan (APEJ)
8.2.6. Japan
8.2.7. Middle East and Africa (MEA)
8.3. Market Attractiveness Analysis By Region
9. North America Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis By Country
9.1.2. Y-o-Y Growth Projections By Country
9.1.3. Key Regulations
9.2. Market Size (US$ Mn) 2015-2028, and Volume (Units) 2015-2028, Forecast By Country
9.2.1. U.S.
9.2.2. Canada
9.3. Market Size (US$ Mn) 2015-2028, Forecast By Product Type
9.3.1. Attenuated Live Vaccines
9.3.2. Conjugate Vaccines
9.3.3. Inactivated Vaccines
9.3.4. Subunit Vaccines
9.3.5. Toxoid Vaccines
9.3.6. DNA Vaccines
9.3.7. Recombinant Vaccines
9.4. Market Size (US$ Mn) 2015-2028, Forecast By Distribution Channel
9.4.1. Veterinary Clinics
9.4.2. Veterinary Hospitals
9.4.3. Veterinary Research Institutes
9.4.4. Retail Pharmacies & Others
9.5. Market Size (US$ Mn) 2015-2028, Forecast By Species Type
9.5.1. Canine
9.5.2. Avian
9.5.3. Feline
9.6. Market Attractiveness Analysis
9.6.1. By Country
9.6.2. By Product Type
9.6.3. By Distribution Channel
9.6.4. By Species Type
10. Latin America Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.1.3. Key Regulations
10.2. Market Size (US$ Mn) 2015-2028, and Volume (Units) 2015-2028, Forecast By Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Market Size (US$ Mn) 2015-2028, Forecast By Product Type
10.3.1. Attenuated Live Vaccines
10.3.2. Conjugate Vaccines
10.3.3. Inactivated Vaccines
10.3.4. Subunit Vaccines
10.3.5. Toxoid Vaccines
10.3.6. DNA Vaccines
10.3.7. Recombinant Vaccines
10.4. Market Size (US$ Mn) 2015-2028, Forecast By Distribution Channel
10.4.1. Veterinary Clinics
10.4.2. Veterinary Hospitals
10.4.3. Veterinary Research Institutes
10.4.4. Retail Pharmacies & Others
10.5. Market Size (US$ Mn) 2015-2028, Forecast By Species Type
10.5.1. Canine
10.5.2. Avian
10.5.3. Feline
10.6. Market Attractiveness Analysis
10.6.1. By Country
10.6.2. By Product Type
10.6.3. By Distribution Channel
10.6.4. By Species Type
11. Western Europe Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis By Country / Region
11.1.2. Y-o-Y Growth Projections By Country
11.1.3. Key Regulations
11.2. Market Size (US$ Mn) and Volume (Units) Forecast By Country / Region
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. Spain
11.2.5. U.K.
11.2.6. BENELUX
11.2.7. Rest of Western Europe
11.3. Market Size (US$ Mn) 2015-2028, Forecast By Product Type
11.3.1. Attenuated Live Vaccines
11.3.2. Conjugate Vaccines
11.3.3. Inactivated Vaccines
11.3.4. Subunit Vaccines
11.3.5. Toxoid Vaccines
11.3.6. DNA Vaccines
11.3.7. Recombinant Vaccines
11.4. Market Size (US$ Mn) 2015-2028, Forecast By Distribution Channel
11.4.1. Veterinary Clinics
11.4.2. Veterinary Hospitals
11.4.3. Veterinary Research Institutes
11.4.4. Retail Pharmacies & Others
11.5. Market Size (US$ Mn) 2015-2028, Forecast By Species Type
11.5.1. Canine
11.5.2. Avian
11.5.3. Feline
11.6. Market Attractiveness Analysis
11.6.1. By Country
11.6.2. By Product Type
11.6.3. By Distribution Channel
11.6.4. By Species Type
12. Eastern Europe Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis By Country
12.1.2. Y-o-Y Growth Projections By Country
12.1.3. Key Regulations
12.2. Market Size (US$ Mn) 2015-2028, and Volume (Units) 2015-2028, Forecast By Country
12.2.1. Russia
12.2.2. Poland
12.2.3. Rest of Eastern Europe
12.3. Market Size (US$ Mn) 2015-2028, Forecast By Product Type
12.3.1. Attenuated Live Vaccines
12.3.2. Conjugate Vaccines
12.3.3. Inactivated Vaccines
12.3.4. Subunit Vaccines
12.3.5. Toxoid Vaccines
12.3.6. DNA Vaccines
12.3.7. Recombinant Vaccines
12.4. Market Size (US$ Mn) 2015-2028, Forecast By Distribution Channel
12.4.1. Veterinary Clinics
12.4.2. Veterinary Hospitals
12.4.3. Veterinary Research Institutes
12.4.4. Retail Pharmacies & Others
12.5. Market Size (US$ Mn) 2015-2028, Forecast By Species Type
12.5.1. Canine
12.5.2. Avian
12.5.3. Feline
12.6. Market Attractiveness Analysis
12.6.1. By Country
12.6.2. By Product Type
12.6.3. By Distribution Channel
12.6.4. By Species Type
13. Asia Pacific Excl. Japan (APEJ) Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis By Country / Region
13.1.2. Y-o-Y Growth Projections By Country / Region
13.1.3. Key Regulations
13.2. Market Size (US$ Mn) 2015-2028, and Volume (Units) 2015-2028, Forecast By Country
13.2.1. China
13.2.2. India
13.2.3. ASEAN
13.2.4. Australia and New Zealand
13.2.5. Rest of APEJ
13.3. Market Size (US$ Mn) 2015-2028, Forecast By Product Type
13.3.1. Attenuated Live Vaccines
13.3.2. Conjugate Vaccines
13.3.3. Inactivated Vaccines
13.3.4. Subunit Vaccines
13.3.5. Toxoid Vaccines
13.3.6. DNA Vaccines
13.3.7. Recombinant Vaccines
13.4. Market Size (US$ Mn) 2015-2028, Forecast By Distribution Channel
13.4.1. Veterinary Clinics
13.4.2. Veterinary Hospitals
13.4.3. Veterinary Research Institutes
13.4.4. Retail Pharmacies & Others
13.5. Market Size (US$ Mn) 2015-2028, Forecast By Species Type
13.5.1. Canine
13.5.2. Avian
13.5.3. Feline
13.6. Market Attractiveness Analysis
13.6.1. By Country
13.6.2. By Product Type
13.6.3. By Distribution Channel
13.6.4. By Species Type
14. Japan Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028
14.1. Introduction
14.1.1. Key Regulations
14.2. Market Size (US$ Mn) 2015-2028, Forecast By Product Type
14.2.1. Attenuated Live Vaccines
14.2.2. Conjugate Vaccines
14.2.3. Inactivated Vaccines
14.2.4. Subunit Vaccines
14.2.5. Toxoid Vaccines
14.2.6. DNA Vaccines
14.2.7. Recombinant Vaccines
14.3. Market Size (US$ Mn) 2015-2028, Forecast By Distribution Channel
14.3.1. Veterinary Clinics
14.3.2. Veterinary Hospitals
14.3.3. Veterinary Research Institutes
14.3.4. Retail Pharmacies & Others
14.4. Market Size (US$ Mn) 2015-2028, Forecast By Species Type
14.4.1. Canine
14.4.2. Avian
14.4.3. Feline
14.5. Market Attractiveness Analysis
14.5.1. By Product Type
14.5.2. By Distribution Channel
14.5.3. By Species Type
15. MEA Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028
15.1. Introduction
15.1.1. Basis Point Share (BPS) Analysis By Country
15.1.2. Y-o-Y Growth Projections By Country
15.1.3. Key Regulations
15.2. Market Size (US$ Mn) 2015-2028, Forecast By Country
15.2.1. GCC Countries
15.2.2. South Africa
15.2.3. Rest of MEA
15.3. Market Size (US$ Mn) 2015-2028, Forecast By Product Type
15.3.1. Attenuated Live Vaccines
15.3.2. Conjugate Vaccines
15.3.3. Inactivated Vaccines
15.3.4. Subunit Vaccines
15.3.5. Toxoid Vaccines
15.3.6. DNA Vaccines
15.3.7. Recombinant Vaccines
15.4. Market Size (US$ Mn) 2015-2028, Forecast By Distribution Channel
15.4.1. Veterinary Clinics
15.4.2. Veterinary Hospitals
15.4.3. Veterinary Research Institutes
15.4.4. Retail Pharmacies & Others
15.5. Market Size (US$ Mn) 2015-2028, Forecast By Species Type
15.5.1. Canine
15.5.2. Avian
15.5.3. Feline
15.6. Market Attractiveness Analysis
15.6.1. By Country
15.6.2. By Product Type
15.6.3. By Distribution Channel
15.6.4. By Species Type
16. Competition Landscape
16.1. Competition Dashboard
16.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
16.3. Global Players
16.3.1. Bayer Healthcare
16.3.1.1. Overview
16.3.1.2. Financials
16.3.1.3. Strategy
16.3.1.4. Recent Developments
16.3.2. Vétoquinol S.A
16.3.2.1. Overview
16.3.2.2. Financials
16.3.2.3. Strategy
16.3.2.4. Recent Developments
16.3.3. Boehringer Ingelheim
16.3.3.1. Overview
16.3.3.2. Financials
16.3.3.3. Strategy
16.3.3.4. Recent Developments
16.3.4. Ceva
16.3.4.1. Overview
16.3.4.2. Financials
16.3.4.3. Strategy
16.3.4.4. Recent Developments
16.3.5. Eli Lilly and Company (Elcano)
16.3.5.1. Overview
16.3.5.2. Financials
16.3.5.3. Strategy
16.3.5.4. Recent Developments
16.3.6. Heska Co.
16.3.6.1. Overview
16.3.6.2. Financials
16.3.6.3. Strategy
16.3.6.4. Recent Developments
16.3.7. Merck Animal Health
16.3.7.1. Overview
16.3.7.2. Financials
16.3.7.3. Strategy
16.3.7.4. Recent Developments
16.3.8. Merial (Sanofi)
16.3.8.1. Overview
16.3.8.2. Financials
16.3.8.3. Strategy
16.3.8.4. Recent Developments
16.3.9. Virbac
16.3.9.1. Overview
16.3.9.2. Financials
16.3.9.3. Strategy
16.3.9.4. Recent Developments
16.3.10. Zoetis (Pfizer)
16.3.10.1. Overview
16.3.10.2. Financials
16.3.10.3. Strategy
16.3.10.4. Recent Developments
17. Assumptions and Acronyms Used
18. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Companion Animal Vaccines Market Value Forecast, By Product Type, 2022-2028 (US$ Mn)
Table 2: Global Companion Animal Vaccines Market Value Forecast, By Distribution Channel, 2022-2028 (US$ Mn)
Table 3: Global Companion Animal Vaccines Market Value Forecast, By Species Type, 2022-2028 (US$ Mn)
Table 4: Global Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Region, 2022-2028
Table 5: North America Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Product Type, 2022-2028
Table 6: North America Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Distribution Channel, 2022-2028
Table 7: North America Companion Animal Vaccines Market Value Forecast, By Species Type, 2022-2028 (US$ Mn)
Table 8: North America Companion Animal Vaccines Market Value Forecast, By Country, 2022-2028 (US$ Mn)
Table 9: Latin America Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Product Type, 2022-2028
Table 10: Latin America Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Distribution Channel, 2022-2028
Table 11: Latin America Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Species Type, 2022-2028
Table 12: Latin America Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Country, 2022-2028
Table 13: Western Europe Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Product Type, 2022-2028
Table 14: Western Europe Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Distribution Channel, 2022-2028
Table 15: Western Europe Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Species Type, 2022-2028
Table 16: Western Europe Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Country, 2022-2028
Table 17: Eastern Europe Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Product Type, 2022-2028
Table 18: Eastern Europe Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Distribution Channel, 2022-2028
Table 19: Eastern Europe Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Species Type, 2022-2028
Table 20: Eastern Europe Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Country, 2022-2028
Table 21: APEJ Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Product Type, 2022-2028
Table 22: APEJ Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Distribution Channel, 2022-2028
Table 23: APEJ Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Species Type, 2022-2028
Table 24: APEJ Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Country, 2022-2028
Table 25: Japan Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Product Type, 2022-2028
Table 26: Japan Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Distribution Channel, 2022-2028
Table 27: Japan Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Species Type, 2022-2028
Table 28: MEA Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Product Type, 2022-2028
Table 29: MEA Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Distribution Channel, 2022-2028
Table 30: MEA Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Species Type, 2022-2028
Table 31: MEA Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Country, 2022-2028
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Companion Animal Vaccines Market Share, by Species Type, 2022 (E)
Figure 2: Global Companion Animal Vaccines Market Share, by Product Type, 2022 (E)
Figure 3: Global Companion Animal Vaccines Market Share, by Distribution Channel, 2022 (E)
Figure 4: Market Share of Prominent Key Players: Companion Animal Vaccines Market, 2021
Figure 5: Global Companion Animal Vaccines Share Analysis (%) By Product Type, 2022 & 2028
Figure 6: Global Companion Animal Vaccines Y-o-Y growth (%) By Product Type, 2021-2028
Figure 7: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Attenuated Live Vaccines, 2022-2028
Figure 8: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Conjugate Vaccines, 2022-2028
Figure 9: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Inactivated Vaccines, 2022-2028
Figure 10: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Subunit Vaccines, 2022-2028
Figure 11: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Toxoid Vaccines, 2022-2028
Figure 12: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By DNA Vaccines, 2022-2028
Figure 13: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Recombinant Vaccines, 2022-2028
Figure 14: Global Companion Animal Vaccines Market Attractiveness Analysis, by Product Type, 2022-2028
Figure 15: Global Companion Animal Vaccines Share Analysis (%) By Distribution Channel, 2022 & 2028
Figure 16: Global Companion Animal Vaccines Y-o-Y growth (%) By Distribution Channel, 2021-2028
Figure 17: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) Veterinary Clinics, 2022-2028
Figure 18: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Veterinary Hospitals, 2022-2028
Figure 19: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) Veterinary Research Institutes, 2022-2028
Figure 20: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Retail Pharmacies, 2022-2028
Figure 21: Global Companion Animal Vaccines Market Attractiveness Analysis, by Distribution Channel, 2022-2028
Figure 22: Global Companion Animal Vaccines Share Analysis (%) By Species Type, 2022 & 2028
Figure 23: Global Companion Animal Vaccines Y-o-Y growth (%) By Species Type, 2021-2028
Figure 24: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) Canine, 2022-2028
Figure 25: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Avian, 2022-2028
Figure 26: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) Feline, 2022-2028
Figure 27: Global Companion Animal Vaccines Market Attractiveness Analysis, By Species Type, 2022-2028
Figure 28: Global Companion Animal Vaccines Share Analysis (%) By Region, 2022 & 2028
Figure 29: Global Companion Animal Vaccines Share Analysis (%) By Region, 2022 & 2028
Figure 30: Global Companion Animal Vaccines Market Attractiveness Analysis, By Region, 2022-2028
Figure 31: North America Companion Animal Vaccines Share Analysis (%) By Product Type, 2022 & 2028
Figure 32: North America Companion Animal Vaccines Y-o-Y growth (%) By Product Type, 2022-2028
Figure 33: North America Companion Animal Vaccines Market Attractiveness Analysis, by Product Type, 2022-2028
Figure 34: North America Companion Animal Vaccines Share Analysis (%) By Distribution Channel, 2022 & 2028
Figure 35: North America Companion Animal Vaccines Y-o-Y growth (%) By Distribution Channel, 2021-2028
Figure 36: North America Companion Animal Vaccines Market Attractiveness Analysis, by Distribution Channel, 2022-2028
Figure 37: North America Companion Animal Vaccines Share Analysis (%) By Species Type, 2022 & 2028
Figure 38: North America Companion Animal Vaccines Y-o-Y growth (%) By Species Type, 2021-2028
Figure 39: North America Companion Animal Vaccines Market Attractiveness Analysis, By Species Type, 2022-2028
Figure 40: North America Companion Animal Vaccines Share Analysis (%) By Country, 2022 & 2028
Figure 41: North America Companion Animal Vaccines Y-o-Y growth (%) By Country, 2021-2028
Figure 42: North America Companion Animal Vaccines Market Attractiveness Analysis, By Country, 2022-2028
Figure 43: Latin America Companion Animal Vaccines Share Analysis (%) By Product Type, 2022 & 2028
Figure 44: Latin America Companion Animal Vaccines Y-o-Y growth (%) By Product Type, 2022-2028
Figure 45: Latin America Companion Animal Vaccines Market Attractiveness Analysis, by Product Type, 2022-2028
Figure 46: Latin America Companion Animal Vaccines Share Analysis (%) By Distribution Channel, 2022 & 2028
Figure 47: Latin America Companion Animal Vaccines Y-o-Y growth (%) By Distribution Channel, 2021-2028
Figure 48: Latin America Companion Animal Vaccines Market Attractiveness Analysis, by Distribution Channel, 2022-2028
Figure 49: Latin America Companion Animal Vaccines Share Analysis (%) By Species Type, 2022 & 2028
Figure 50: Latin America Companion Animal Vaccines Y-o-Y growth (%) By Species Type, 2021-2028
Figure 51: Latin America Companion Animal Vaccines Market Attractiveness Analysis, By Species Type, 2022-2028
Figure 52: Latin America Companion Animal Vaccines Share Analysis (%) By Country, 2022 & 2028
Figure 53: Latin America Companion Animal Vaccines Y-o-Y growth (%) By Country, 2021-2028
Figure 54: Latin America Companion Animal Vaccines Market Attractiveness Analysis, By Country, 2022-2028
Figure 55: Western Europe Companion Animal Vaccines Share Analysis (%) By Product Type, 2022 & 2028
Figure 56: Western Europe Companion Animal Vaccines Y-o-Y growth (%) By Product Type, 2022-2028
Figure 57: Western Europe Companion Animal Vaccines Market Attractiveness Analysis, by Product Type, 2022-2028
Figure 58: Western Europe Companion Animal Vaccines Share Analysis (%) By Distribution Channel, 2022 & 2028
Figure 59: Western Europe Companion Animal Vaccines Y-o-Y growth (%) By Distribution Channel, 2021-2028
Figure 60: Western Europe Companion Animal Vaccines Market Attractiveness Analysis, by Distribution Channel, 2022-2028
Figure 61: Western Europe Companion Animal Vaccines Share Analysis (%) By Species Type, 2022 & 2028
Figure 62: Western Europe Companion Animal Vaccines Y-o-Y growth (%) By Species Type, 2022-2028
Figure 63: Western Europe Companion Animal Vaccines Market Attractiveness Analysis, By Species Type, 2022-2028
Figure 64: Western Europe Companion Animal Vaccines Share Analysis (%) By Country, 2022 & 2028
Figure 65: Western Europe Companion Animal Vaccines Y-o-Y growth (%) By Country, 2022-2028
Figure 66: Western Europe Companion Animal Vaccines Market Attractiveness Analysis, By Country, 2022-2028
Figure 67: Eastern Europe Companion Animal Vaccines Share Analysis (%) By Product Type, 2022 & 2028
Figure 68: Eastern Europe Companion Animal Vaccines Y-o-Y growth (%) By Product Type, 2021-2028
Figure 69: Eastern Europe Companion Animal Vaccines Market Attractiveness Analysis, by Product Type, 2022-2028
Figure 70: Eastern Europe Companion Animal Vaccines Share Analysis (%) By Distribution Channel, 2022 & 2028
Figure 71: Eastern Europe Companion Animal Vaccines Y-o-Y growth (%) By Distribution Channel, 2021-2028
Figure 72: Eastern Europe Companion Animal Vaccines Market Attractiveness Analysis, by Distribution Channel, 2022-2028
Figure 73: Eastern Europe Companion Animal Vaccines Share Analysis (%) By Species Type, 2022 & 2028
Figure 74: Eastern Europe Companion Animal Vaccines Y-o-Y growth (%) By Species Type, 2021-2028
Figure 75: Eastern Europe Companion Animal Vaccines Market Attractiveness Analysis, By Species Type, 2022-2028
Figure 76: Eastern Europe Companion Animal Vaccines Share Analysis (%) By Country, 2022 & 2028
Figure 77: Eastern Europe Companion Animal Vaccines Y-o-Y growth (%) By Country, 2021-2028
Figure 78: Eastern Europe Companion Animal Vaccines Market Attractiveness Analysis, By Country, 2022-2028
Figure 79: APEJ Companion Animal Vaccines Share Analysis (%) By Product Type, 2022 & 2028
Figure 80: APEJ Companion Animal Vaccines Y-o-Y growth (%) By Product Type, 2022-2028
Figure 81: APEJ Companion Animal Vaccines Market Attractiveness Analysis, by Product Type, 2022-2028
Figure 82: APEJ Companion Animal Vaccines Share Analysis (%) By Distribution Channel, 2022 & 2028
Figure 83: APEJ Companion Animal Vaccines Y-o-Y growth (%) By Distribution Channel, 2021-2028
Figure 84: APEJ Companion Animal Vaccines Market Attractiveness Analysis, by Distribution Channel, 2022-2028
Figure 85: APEJ Companion Animal Vaccines Share Analysis (%) By Species Type, 2022 & 2028
Figure 86: APEJ Companion Animal Vaccines Y-o-Y growth (%) By Species Type, 2021-2028
Figure 87: APEJ Companion Animal Vaccines Market Attractiveness Analysis, By Species Type, 2022-2028
Figure 88: APEJ Companion Animal Vaccines Share Analysis (%) By Country, 2022 & 2028
Figure 89: APEJ Companion Animal Vaccines Y-o-Y growth (%) By Country, 2021-2028
Figure 90: APEJ Companion Animal Vaccines Market Attractiveness Analysis, By Country, 2022-2028
Figure 91: Japan Companion Animal Vaccines Share Analysis (%) By Product Type, 2022 & 2028
Figure 92: Japan Companion Animal Vaccines Y-o-Y growth (%) By Product Type, 2021-2028
Figure 93: Japan Companion Animal Vaccines Market Attractiveness Analysis, by Product Type, 2022-2028
Figure 94: Japan Companion Animal Vaccines Share Analysis (%) By Distribution Channel, 2022 & 2028
Figure 95: Japan Companion Animal Vaccines Y-o-Y growth (%) By Distribution Channel, 2021-2028
Figure 96: Japan Companion Animal Vaccines Market Attractiveness Analysis, by Distribution Channel, 2022-2028
Figure 97: Japan Companion Animal Vaccines Share Analysis (%) By Species Type, 2022 & 2028
Figure 98: Japan Companion Animal Vaccines Y-o-Y growth (%) By Species Type, 2021-2028
Figure 99: Japan Companion Animal Vaccines Market Attractiveness Analysis, By Species Type, 2022-2028
Figure 100: MEA Companion Animal Vaccines Share Analysis (%) By Product Type, 2022 & 2028
Figure 101: MEA Companion Animal Vaccines Y-o-Y growth (%) By Product Type, 2021-2028
Figure 102: MEA Companion Animal Vaccines Market Attractiveness Analysis, by Product Type, 2022-2028
Figure 103: MEA Companion Animal Vaccines Share Analysis (%) By Distribution Channel, 2022 & 2028
Figure 104: MEA Companion Animal Vaccines Y-o-Y growth (%) By Distribution Channel, 2021-2028
Figure 105: MEA Companion Animal Vaccines Market Attractiveness Analysis, by Distribution Channel, 2022-2028
Figure 106: MEA Companion Animal Vaccines Share Analysis (%) By Species Type, 2022 & 2028
Figure 107: MEA Companion Animal Vaccines Y-o-Y growth (%) By Species Type, 2021-2028
Figure 108: MEA Companion Animal Vaccines Market Attractiveness Analysis, By Species Type, 2022-2028
Figure 109: MEA Companion Animal Vaccines Share Analysis (%) By Country/Region, 2022 & 2028
Figure 110: MEA Companion Animal Vaccines Y-o-Y growth (%) By Country/Region, 2021-2028
Figure 111: MEA Companion Animal Vaccines Market Attractiveness Analysis, By Country/Region, 2022-2028
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
